Legal & General Group’s Apogee Therapeutics APGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
27,689
+1,907
| +7% | +$82.8K | ﹤0.01% | 2176 |
|
|
2025
Q1 | $963K | Sell |
25,782
-91
| -0.4% | -$3.4K | ﹤0.01% | 2200 |
|
|
2024
Q4 | $1.17M | Buy |
25,873
+5,003
| +24% | +$227K | ﹤0.01% | 2181 |
|
|
2024
Q3 | $1.23M | Sell |
20,870
-218
| -1% | -$12.8K | ﹤0.01% | 2163 |
|
|
2024
Q2 | $830K | Buy |
21,088
+829
| +4% | +$32.6K | ﹤0.01% | 2254 |
|
|
2024
Q1 | $1.35M | Buy |
20,259
+9,922
| +96% | +$659K | ﹤0.01% | 2088 |
|
|
2023
Q4 | $289K | Buy |
10,337
+7,157
| +225% | +$200K | ﹤0.01% | 2637 |
|
|
2023
Q3 | $67.7K | Buy |
+3,180
| New | +$67.7K | ﹤0.01% | 2850 |
|